… comprehensive management of patients with atrial fibrillation (AF)… for the use of the
ABC pathway on clinical outcomes. … in AF patients, and its impact on clinical outcomes (all-cause …

… most of the patients treated with DOACs for stroke prevention in atrial fibrillation received
doses in accordance to the guidelines. However, a significant number of patients received off‐…

… We aimed to perform cluster analysis in a cohort of AF patients and to assess the outcomes
and … associated with the incidence of clinical outcomes. Clinical Trial Registration Information …

… On the other hand, this study found a clear impact of AF burden on clinical outcomes after
ablation, with a clear benefit in patients with AF burden <50% post-ablation (Figures 2 and 3, …

… Clinical Outcomes After 3 years of follow-up, we analyzed adverse clinical outcomes according
to each ABC criterion fulfilled and the “ABC pathway adherent group.” Thromboembolic …

… This study aims to report clinical outcomes of patients with AF in the Effective Anticoagulation
with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction …

… adverse clinical outcomes during follow-up, our findings strongly suggest the need for
ensuring the best available management to patients with AF at higher risk, such as patients with …

… clinical outcomes among AF patients having LAAO after enrollment in the Amulet
Observational Study (n = 1,078) versus propensity score–matched AF patients treated by DOACs. …

… stroke and bleeding outcomes in anticoagulated patients, we assessed 2-year outcomes in
patients with AF treated … We also report the age-adjusted risk predictors of clinical outcomes. …

… clinical outcome of patients with atrial fibrillation (AF). The authors concluded that only apixaban
significantly decreases the rate of several clinical outcomes … studies for patients with AF, …